recurrence risk


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.
Related to recurrence risk: Relative risk

re·cur·rence risk

risk that a disease will occur elsewhere in a pedigree, given that at least one member of the pedigree (the proband) exhibits the disease.

recurrence risk

the chance that a disease found in one member of a proband will appear in other members of the same pedigree.

re·cur·rence risk

(rĕ-kŭr'ĕns risk)
Chance or possibility that a disease will occur elsewhere in a pedigree, given that at least one member of the pedigree (the proband) exhibits the disease.

recurrence

the return of clinical signs soon after a remission.

recurrence risk
in genetics the probability of a particular defect occurring again if the type of mating which produced it is repeated.
References in periodicals archive ?
The principal contribution of this paper is the estimation of a forward-looking measure of conflict recurrence risk and its use as an explanatory variable in estimating the determinants of post-conflict economic performance.
It is important to recognise this to allow for accurate recurrence risk estimation and genetic counselling.
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
The study, conducted by the Department of Surgery at the Leiden University Medical Centre, evaluated the Recurrence Score results and recurrence risk in rectal cancer patients from the landmark Dutch Total Mesorectal Excision (TME) trial.
The current study, led by Dennis Sgroi, MD, of the MGH Cancer Center and Department of Pathology, was designed to compare the ability of the BCI to predict long-term recurrence risk with that of two other gene-expression signatures that can predict risk in the first five years.
Although the recurrence risk is never zero, owing to possible germline mosaicism in an unaffected parent, families can be reassured that the risk for future pregnancies is very low.
The only significant predictor of increased recurrence risk was prostatic involvement.
A NEW breast cancer treatment that can cut recurrence risk and replace the standard six- week post- surgical therapy has debuted in India.
An ongoing randomised controlled trial is examining whether or not the increased local recurrence risk of focally positive or close margins can be counterbalanced by increasing the boost dose, since further re-excision surgery is often technically difficult and it is seldom that any residual tumour is found in the re-excision specimen.
Taxane-based therapy in women younger than age 50 conferred a 16% reduction in recurrence risk, compared with anthracycline-based regimens, and a 14% reduction in breast cancer mortality through the first 4 years of follow-up.